Evergreen Therapeutics, Inc.
PrivateLast Round
Series A
Extension
Jun 17, 2024
Total Funding Raised
$15M
Company Overview
Evergreen Therapeutics, Inc. is a biotechnology company that develops novel drug candidates for unmet medical needs using an AI-powered drug discovery and development platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evergreen Therapeutics, Inc. Comparables
Compare Evergreen Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Artivila Biopharma | 88% | |
| Genesis Therapeutics | 80% | |
| MindRank | 79% |
Evergreen Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 17, 2024 | ||||
| Series A | Mar 1, 2021 | ||||
| Angel | Mar 16, 2020 |
Key People
Founding team and executive leadership
Evergreen Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tiantu Capital | Series A |
| Share Capital | Angel |
| SB China Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors increased 141% MoM.
- Jun 17, 2024
Raised Series A Extension with SB China Capital and Yantai Biomedical Health Industry Development Parent Fund.
Evergreen Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Evergreen Therapeutics, Inc.'s valuation, stock price, and market status.
Is Evergreen Therapeutics, Inc. a public or private company?
Evergreen Therapeutics, Inc. is a private company.
What is the current stock price of Evergreen Therapeutics, Inc.?
Evergreen Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Evergreen Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evergreen Therapeutics, Inc. worth (valuation)?
Valuation information for Evergreen Therapeutics, Inc. is not publicly available.
Can I buy Evergreen Therapeutics, Inc. stock?
Evergreen Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evergreen Therapeutics, Inc.'s last funding round?
Evergreen Therapeutics, Inc.'s most recent funding round was Series A Extension on June 17, 2024.
Who are the main investors in Evergreen Therapeutics, Inc.?
Key investors in Evergreen Therapeutics, Inc. include Tiantu Capital.
Will Evergreen Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Evergreen Therapeutics, Inc..
How can I track Evergreen Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Evergreen Therapeutics, Inc.'s shares on secondary markets.